Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety, over 6 months, of 6
dose regimens of CP-690,550, combined with methotrexate, for the treatment of adults with
active rheumatoid arthritis.